Class a ordinary shares subject to possible redemption, 0.0001 par value 14,651,303 and 17,250,000 shares issued and outstanding at redemption value of 10.73 and 10.53 per share as of june 30, 2026 and december 31, 2025, respectively
157,261,867
183,271,269
181,657,311
179,899,077
Common stock
466
0
-
-
Common stock-Common Class B
-
466
466
466
Accumulated deficit
-7,684,785
-6,823,735
-6,542,574
-6,380,229
Total shareholders' deficit
-7,684,319
-6,823,269
-6,542,108
-6,379,763
Total liabilities, class a ordinary shares subject to possible redemption, and shareholders' deficit
157,366,598
183,346,585
181,696,776
179,979,659
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Translational Development Acquisition Corp. (TDACU)
Translational Development Acquisition Corp. (TDACU)